Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated with t(8;9)(p22;p24) and PCM1-JAK2 Fusion Gene

被引:0
|
作者
Casetti, Ilaria [1 ]
Rumi, Elisa [1 ]
Milosevic, Jelena D. [2 ]
Dambruoso, Irene [1 ]
Pietra, Daniela [1 ]
Boveri, Emanuela [3 ]
Boni, Marina [1 ]
Bernasconi, Paolo [1 ]
Passamonti, Francesco [4 ,5 ]
Kralovics, Robert [2 ]
Cazzola, Mario [1 ]
机构
[1] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Hematol Oncol, I-27100 Pavia, Italy
[2] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria
[3] Univ Pavia, Fdn IRCCS Policlin San Matteo, Dept Human Human Pathol, I-27100 Pavia, Italy
[4] Osped Circolo Varese, Dept Internal Med, Div Hematol, Varese, Italy
[5] Fdn Macchi, Varese, Italy
关键词
D O I
10.1182/blood.V120.21.2833.2833
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2833
引用
收藏
页数:2
相关论文
共 50 条
  • [1] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene
    Bousquet, M
    Quelen, C
    De Mas, V
    Duchayne, E
    Roquefeuil, B
    Delsol, G
    Laurent, G
    Dastugue, N
    Brousset, P
    ONCOGENE, 2005, 24 (48) : 7248 - 7252
  • [2] Efficacy of Ruxolitinib in Chronic Eosinophilic Leukemia Associated With a PCM1-JAK2 Fusion Gene
    Rumi, Elisa
    Milosevic, Jelena D.
    Casetti, Ilaria
    Dambruoso, Irene
    Pietra, Daniela
    Boveri, Emanuela
    Boni, Marina
    Bernasconi, Paolo
    Passamonti, Francesco
    Kralovics, Robert
    Cazzola, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (17) : E269 - E271
  • [3] The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene
    Marina Bousquet
    Cathy Quelen
    Véronique De Mas
    Eliane Duchayne
    Blandine Roquefeuil
    Georges Delsol
    Guy Laurent
    Nicole Dastugue
    Pierre Brousset
    Oncogene, 2005, 24 : 7248 - 7252
  • [4] Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?
    Prochorec-Sobieszek, Monika
    Nasilowska-Adamska, Barbara
    Borg, Katarzyna
    Kopec, Izabella
    Kos-Zakrzewska, Kinga
    Juszczynski, Przemyslaw
    Warzocha, Krzysztof
    LEUKEMIA & LYMPHOMA, 2012, 53 (09) : 1824 - 1827
  • [5] MOLECULAR MONITORING OF PCM1-JAK2 FUSION TRANSCRIPT IN A CASE OF ATYPICAL CHRONIC MYELOID LEUKEMIA WITH T(8;9)(P22;24)
    Masselli, E.
    Prezioso, L.
    Mecucci, C.
    Sammarelli, G.
    Bonomini, S.
    Lambertini, C.
    Craviotto, L.
    Rossetti, E.
    Caramatti, C.
    Vitale, M.
    Aversa, F.
    HAEMATOLOGICA, 2014, 99 : 669 - 669
  • [6] Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)/PCM1-JAK2-positive chronic eosinophilic leukemia
    Lierman, Els
    Selleslag, Dominik
    Smits, Sanne
    Billiet, Johan
    Vandenberghe, Peter
    BLOOD, 2012, 120 (07) : 1529 - 1531
  • [7] The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2
    Reiter, A
    Walz, C
    Watmore, A
    Schoch, C
    Blau, I
    Schlegelberger, B
    Berger, U
    Telford, N
    Aruliah, S
    Yin, JA
    Vanstraelen, D
    Barker, HF
    Taylor, PC
    O'Driscoll, A
    Benedetti, F
    Rudolph, C
    Kolb, HJ
    Hochhaus, A
    Hehlmann, R
    Chase, A
    Cross, NCP
    CANCER RESEARCH, 2005, 65 (07) : 2662 - 2667
  • [8] Chronic eosinophilic leukaemia with erythroblastic proliferation and the recurrent chromosomal translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene - a distinct clinical, pathological and genetic entity successfully treated with alloHSCT
    Nasilowska-Adamska, B.
    Prochorec-Sobieszek, M.
    Borg, K.
    Tomaszewska, A.
    Marianska, B.
    Warzocha, K.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S433 - S434
  • [9] A t(8;9)(p22;p24)/PCM1-JAK2 Translocation in a Patient With Myeloproliferative Neoplasm and Myeloid Sarcoma: First Report in Korea
    Song, Ilgeun
    Lee, Dong-hyun
    Lee, Je-Hwan
    Jang, Seongsoo
    Huh, Joo-Ryung
    Seo, Eul-Ju
    ANNALS OF LABORATORY MEDICINE, 2016, 36 (01) : 79 - 81
  • [10] T(8;9)(p22;p24)/PCM1-JAK2 Activates SOCS2 and SOCS3 Via STAT5
    Ehrentraut, Stefan
    Nagel, Stefan
    Scherr, Michaela
    Schneider, Bjoern
    Quentmeier, Hilmar
    Geffers, Robert
    Prochorec-Sobieszek, Monika
    Ketterling, Rhett P.
    Knudson, Ryan A.
    Feldman, Andrew L.
    Kadin, Marshall
    Drexler, Hans G.
    MacLeod, Roderick A. F.
    BLOOD, 2012, 120 (21)